MedTrace Logo

CoreHip - Post Market Clinical Follow-Up Study

NCT03685110 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 248

Last updated 2026-03-31

No results posted yet for this study

Summary

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

Conditions

  • Degenerative Osteoarthritis
  • Rheumatic Arthritis
  • Fractures, Hip
  • Necrosis, Femur Head

Interventions

DEVICE

CoreHip Total Hip Arthroplasty

Replacement of the Hip Joint

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Henning Windhagen, Prof. Dr. med. · Orthopädische Kliniken im Annastift, Medizinische Hochschule Hannover

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-16
Primary Completion
2023-04-30
Completion
2028-12-31

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03685110 on ClinicalTrials.gov